2008.9.02 Announcement of corporate name alteration and new board members 2008.10.15 Brief Report on the Account Settlement for the First Quarter of Term Ending in May 2009 2008.9.25 ECI Enters into a Joint Research Agreement for Development of a Novel Antibody Drug against Cancer 2008.9.22 ECI has Succeeded in Production of Cancer Drug for Clinical Trial(ECI301) 2008.7.30 Business Program for Fiscal Year 2008 and 2009 2008.7.15 Brief Report on the Account Settlement for Term Ending in May 2008 2008.6.06 ECI Enters into Partnership with Fujinon Corporation 2008.5.30 Annoucement on the Change of Representative Directors and Directors 2008.5.30 Announcement of Joint Research Agreement with the National Institute on Aging (NIA) 2008.5.14 ECI Enters into a Sponsored Research Agreement with L'Oreal 2008.4.14 Summary of Financial Report for the 3rd Quarter FY2007(Ending May 31,2008) 2008.4.11 Notice on Exercise of Subscription Rights, Subscription Book Closed, and Change in Major Shareholders 2008.4.04 Announcement of Joint Research Agreement to be Concluded with the National Institute on Aging(NIA) 2008.3.12 ECI at BioSquare 2008 2008.2.18 Announcement of publication in Clinical Cancer Research of ECI301 study demonstrating enhanced 'abscopal effect' effective for metastatic cancers 2008.2.15 ECI Enters into a Joint Research Agreement with the Dept.of Biochemistry & Biophysic, University of California, San Francisco(UCSF) 2008.2.13 ECI Signed a Joint Research Agreement with Astellas Pharma Inc. 2007.12.11 ECI Enters into Partnership with GE Healthcare Bio-Sciences Ltd. 2007.12.03 ECI Enters into Partnership with GE Medical Systems Hong Kong Limited 2007.2.01 ECI and GE Healthcare Bio-sciences KK Made a Contract for a Comprehensive business tie-up 2006.11.15 【PR】Establishment of the Central Laboratory 2006.10.20 ECI’s announcement at the 44th annual conference of the Japanese Cancer Association regarding anticancer therapy through a combination treatment of eMIP and radiation is awarded the iPos Award 2006.9.26 Announcement at the Japanese Cancer Association regarding embryonic stem (ES) cell research ; Pancreas differentiation of ES cells in vivo 2006.9.06 Announcement of recent discoveries presented at the International Congress of Metastasis Research Society regarding anticancer effects of radiation therapy combined with eMIP treatment 2006.5.21 ECI renewed its homepage. 2006.4.09 ECI exhibited to BIO 2006 in Chicago. 2006.1.05 ECI signed agreement with AstraZeneca. 2005.3.29 ECI announced Initial Public Offering. 2004.11.06 ECI attended the 27th annual meeting of the molecular biology society of Japan. 2004.9.28 ECI attended the 77th Annual Meeting of the Japanese Biochemical Society. 日本語｜SITE MAP Copyright 2008 ECI, Inc. All rights reserved.